Kazia Therapeutics (KZIA) Depreciation & Amortization (CF) (2009 - 2020)
Kazia Therapeutics (KZIA) posted Depreciation & Amortization (CF) of $396292.4 for Q4 2020, down 48.58% on a QoQ basis from $770637.4 in Q4 2017.
Kazia Therapeutics (KZIA) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $396292.4 in Q4 2020.
- In Q4 2020, Depreciation & Amortization (CF) changed N/A year-over-year to $396292.4; the TTM figure through Dec 2022 stood at $396292.4 (changed N/A YoY), while the FY2025 annual figure was $598164.6, down 51.44% from the prior year.
- Depreciation & Amortization (CF) retreated to $396292.4 in Q4 2020, from $770637.4 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $770637.4 in Q4 2017 and bottomed at $396292.4 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 396,292.37 |
| Dec 31, 2020 | 396,292.37 |
| Dec 31, 2017 | 770,637.39 |
| Dec 31, 2017 | 770,637.39 |
| Dec 31, 2011 | -83,917.17 |
| Dec 31, 2011 | -83,917.17 |
| Dec 31, 2010 | -195,546.29 |
| Dec 31, 2010 | -195,546.29 |
| Dec 31, 2009 | -256,324.49 |
| Dec 31, 2009 | -256,324.49 |